Insider · CIK 0002050167
Atul Dandekar
officer
Files at MAZE (Maze Therapeutics, Inc.). First filing Dec 31, 2025, latest Oct 1, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $3.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MAZE: Maze Therapeutics, Inc.
MAZEOct 9, 2026 · close 27.11
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | Maze Therapeutics, Inc. | $203k 7,500 shares | -19% | +21% from low-48% from high | |
| 46Moderate | Maze Therapeutics, Inc. | $169k 6,434 shares | -17% | - | |
| 40Moderate | Maze Therapeutics, Inc. | $2.9M 72,500 shares | -87% | +436% from low-5% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | MAZE Maze Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +7,500 | $10.42 | $78k | 39,816 | 11 d ago |
| Sep 29, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -7,500 | $27.06 | $203k | 32,316 | 11 d ago |
| Sep 29, 2026 | MAZE Maze Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 6,643 | 11 d ago |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -2,800 | $26.38 | $74k | 35,950 | 38 d ago |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -391 | $27.12 | $11k | 35,559 | 38 d ago |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -3,207 | $26.01 | $83k | 32,352 | 38 d ago |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock | -36 | $25.81 | $929 | 32,316 | 38 d ago |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | MOption exercise Common Stock | +12,500 | $0.00 | $0 | 38,750 | 39 d ago |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -12,500 | $0.00 | $0 | 12,500 | 39 d ago |
| Dec 29, 2025 | MAZE Maze Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +72,400 | $10.42 | $754k | 82,903 | Dec 31, 2025 |
| Dec 29, 2025 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -66,365 | $40.51 | $2.7M | 16,538 | Dec 31, 2025 |
| Dec 29, 2025 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,035 | $41.13 | $248k | 10,503 | Dec 31, 2025 |
| Dec 30, 2025 | MAZE Maze Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +100 | $10.42 | $1,042 | 10,603 | Dec 31, 2025 |
| Dec 30, 2025 | MAZE Maze Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $40.36 | $4,036 | 10,503 | Dec 31, 2025 |
| Dec 29, 2025 | MAZE Maze Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -72,400 | $0.00 | $0 | 74,243 | Dec 31, 2025 |
| Dec 30, 2025 | MAZE Maze Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -100 | $0.00 | $0 | 74,143 | Dec 31, 2025 |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +25,000 | $0.00 | $0 | 25,000 | Sep 24, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.